Cite
HARVARD Citation
Bhusari, P. et al. (n.d.). Development of Lu‐177‐trastuzumab for radioimmunotherapy of HER2 expressing breast cancer and its feasibility assessment in breast cancer patients. International journal of cancer. 140 (4), pp. 938-947. [Online].